TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
SDS Life Science AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
74,741
|
79,479
|
79,806 |
| Financial expenses |
0
|
666
|
1,397 |
| Earnings before taxes |
8,013
|
-3,382
|
-2,477 |
| EBITDA |
8,649
|
-1,937
|
-1,087 |
| Total assets |
40,416
|
28,128
|
30,177 |
| Current assets |
36,730
|
23,861
|
26,431 |
| Current liabilities |
15,729
|
12,858
|
13,325 |
| Equity capital |
8,987
|
2,670
|
1,052 |
| - share capital |
200
|
200
|
200 |
| Employees (average) |
42
|
50
|
45 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
22.2%
|
9.5%
|
3.5% |
| Turnover per employee |
1,780
|
1,590
|
1,773 |
| Profit as a percentage of turnover |
10.7%
|
-4.3%
|
-3.1% |
| Return on assets (ROA) |
19.8%
|
-9.7%
|
-3.6% |
| Current ratio |
233.5%
|
185.6%
|
198.4% |
| Return on equity (ROE) |
89.2%
|
-126.7%
|
-235.5% |
| Change turnover |
-4,738
|
-327
|
12,731 |
| Change turnover % |
-6%
|
0%
|
19% |
| Chg. No. of employees |
-8
|
5
|
11 |
| Chg. No. of employees % |
-16%
|
11%
|
32% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.